Stereotaxis' EMAGIN Catheter: A New Era in Endovascular Procedures

Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, has submitted its EMAGIN™ 5F catheter for regulatory clearance, marking a significant milestone in the expansion of Robotic Magnetic Navigation into the broader endovascular field. The EMAGIN brand, short for Endovascular Magnetic Intervention, encompasses a comprehensive portfolio of robotic catheters and wires, with the EMAGIN 5F being the first in this family of robotically navigated endovascular devices.

The EMAGIN 5F catheter is a 5-French diameter catheter guide designed to navigate tortuous venous and arterial vasculature efficiently and safely. Utilizing precise magnetic fields for robotic navigation directly from the distal tip, the catheter enables efficient and safe navigation to otherwise difficult-to-reach vascular anatomy. This expands the established benefits of Robotic Magnetic Navigation into multiple new clinical applications, including minimally-invasive procedures used to treat stroke, cancer, and cardiovascular disease.